pharma · Total Laryngectomy · Breast Cancer · ATOS
ATOSSA THERAPEUTICS
ATOSSA THERAPEUTICS, INC.
ATOSSA THERAPEUTICS patent portfolio — 8 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Torrance, USA
- Founded
- 2019
- Employees
- 36
- Programs
- 10
- Drugs
- 5
- Patents
- 8
ATOSSA THERAPEUTICS patents
8 pharmaceutical patents indexed for ATOSSA THERAPEUTICS. 0 expire within 24 months.
ATOSSA THERAPEUTICS has 8 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12281056
Methods for making and using endoxifen
granted -
US 12275684
Methods for making and using endoxifen
granted -
US 12201591
Sustained release compositions of endoxifen
granted -
US 12071391
Methods for making and using endoxifen
granted -
US 11680036
Methods for making and using endoxifen
granted -
US 11572334
Methods for making and using endoxifen
granted -
US 11261151
Methods for making and using endoxifen
granted -
US 6894026
Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
expired
Frequently asked questions
How many patents does ATOSSA THERAPEUTICS have?
8 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do ATOSSA THERAPEUTICS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.